Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 1.93 | 1.39 |
NAV | ₹19.39 | ₹1946.12 |
Fund Started | 23 Apr 2021 | 08 Dec 1994 |
Fund Size | ₹2508.97 Cr | ₹74105.46 Cr |
Exit Load | Exit load of 1% if redeemed within 365 Days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 14.67% | 14.94% |
3 Year | 19.65% | 24.95% |
5 Year | - | 31.22% |
1 Year
3 Year
5 Year
Equity | 93.81% | 87.46% |
Cash | 6.19% | 11.02% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.24% |
HDFC Bank Ltd. | 8.31% |
Bharti Airtel Ltd. | 4.64% |
Reliance Industries Ltd. | 4.15% |
TVS Motor Company Ltd. | 3.82% |
Infosys Ltd. | 3.81% |
Bajaj Finance Ltd. | 3.67% |
Trent Ltd. | 3.51% |
Divi's Laboratories Ltd. | 3.42% |
Larsen & Toubro Ltd. | 3.41% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.44% |
HDFC Bank Ltd. | 9.35% |
Axis Bank Ltd. | 8.48% |
Kotak Mahindra Bank Ltd. | 4.92% |
SBI Life Insurance Company Ltd. | 4.65% |
Maruti Suzuki India Ltd. | 4.13% |
Cipla Ltd. | 4.12% |
Bharti Airtel Ltd. | 2.89% |
HCL Technologies Ltd. | 2.64% |
Piramal Pharma Ltd. | 2.32% |
Name | Amit Kadam | Dhruv Muchhal |
Start Date | 01 Oct 2021 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation/income by investing in equity and equity related instruments across market capitalization of up to 30 companies. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 23 Apr 2021 | 08 Dec 1994 |
Description
Launch Date